Search research articles
Contact Us
Filters
Showing results (461-470 of 594) with videos related to
Page
of 60
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial
Merrill S Kies, Floyd Christopher Holsinger, J Jack Lee, et al.
The Lancet. Oncology
|
March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
Masanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2021
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
Vincent K Lam, Jianjun Zhang, Carol C Wu, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy
Meghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Cancers
|
March 13, 2024
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy
Kang Qin, Kaiwen Wang, Shenduo Li, et al.
Annals of Surgery
|
September 2, 2022
High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed
Erin M Bayley, Megan L Ivy, Jitesh B Shewale, et al.
Nature Medicine
|
April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Frontiers in Immunology
|
December 28, 2023
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events
Mehmet Altan, Quan-Zhen Li, Qi Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2023
Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Renata Ferrarotto, Yoshitsugu Mitani, Daniel J McGrail, et al.
Page
of 60
Search research articles
Search
Showing results (461-470 of 594) with videos related to
Sort By:
Page
of 60
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial
Merrill S Kies, Floyd Christopher Holsinger, J Jack Lee, et al.
The Lancet. Oncology
|
March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
Masanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2021
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
Vincent K Lam, Jianjun Zhang, Carol C Wu, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy
Meghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Cancers
|
March 13, 2024
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy
Kang Qin, Kaiwen Wang, Shenduo Li, et al.
Annals of Surgery
|
September 2, 2022
High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed
Erin M Bayley, Megan L Ivy, Jitesh B Shewale, et al.
Nature Medicine
|
April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Frontiers in Immunology
|
December 28, 2023
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events
Mehmet Altan, Quan-Zhen Li, Qi Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2023
Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Renata Ferrarotto, Yoshitsugu Mitani, Daniel J McGrail, et al.
Page
of 60